Imaging Endpoints Continues Global Expansion
ESTABLISHES EUROPEAN OFFICE IN THE NETHERLANDS
News provided by
Share this article
Share this article
SCOTTSDALE, Ariz., Feb. 25, 2021 /PRNewswire/ Imaging Endpoints (IE) announced today that it has established a new office location in Leiden, Netherlands as part of its continuing global expansion into Asia and Europe. The Company now has offices in Scottsdale, Arizona, USA; Waltham, Massachusetts, USA; Hyderabad, India; and Leiden, Netherlands. Additional offices in Basel, Switzerland and Shanghai, China are expected to also open soon.
Imaging Endpoints is one of the largest Imaging CROs (iCROs) globally and is believed to be the fastest-growing iCRO over the last decade due to its focus on leading the industry in radiology science, technology, and regulatory compliance. IE is well-recognized for conducting the industry s largest and most complex registration trials, as well as many early phase trials, and is known for its imp
Imaging Endpoints Leading The Imaging CRO Industry
CONTINUES RECORD OF INSPECTION EXCELLENCE
News provided by
Share this article
Share this article
SCOTTSDALE, Ariz., Feb. 17, 2021 /PRNewswire/ Imaging Endpoints (IE) announced today that it concluded another FDA BIMO inspection at its corporate offices last week with no observations. The inspection was for the Company s work on an extraordinarily complex registration trial for a
18F-based PSMA-targeted PET imaging agent that enables visualization of primary tumors as well as bone and soft tissue metastases. This result continues the Company s perfect record for regulatory inspections and re-emphasizes its growing leadership in contributing to new drug approvals.
Imaging Endpoints Appoints Elliot Fishman To Scientific Advisory Board
World-Class Radiologist To Help Guide Imaging Efforts
News provided by
Share this article
Share this article
SCOTTSDALE, Ariz., Jan. 13, 2021 /PRNewswire/ Imaging Endpoints announced today Elliot K. Fishman, MD, the Elliot K. Fishman Professor in Radiology at Johns Hopkins, has been appointed to its prestigious Scientific Advisory Board.
Elliot Fishman is currently the Director of Diagnostic Imaging and Body Computed Tomography (CT) in the Russell H. Morgan Department of Radiology and Radiological Science, and Professor of Radiology, Surgery, Oncology and Urology at Johns Hopkins. Additionally, he serves as co-principal investigator of the Felix Project for Early Detection of Pancreatic Cancer, focused on using deep learning and artificial intelligence for medical imaging.
legislation. to what extent our staff levels ability to have clearl a high-tech trading? thank you. the richest of reaching our 2005 levels. we have been enormously fortunate to be able to attract a minutes immensely talented staff. there are people from hedge funds and trading desks to help as had the ability to do the job we have always been charged with. it is essential that we bring that kind of cells thaskill sete agency. rohm & hoss in order to make use of adaptive we would receive, even understanding the exchanges, we need people with management, quantitative analysis and capability to see something on the order. it is to respect of our oversight marketplace. i do think our agency will be asked to take on the market. it is nearly 20 times the size and if our economy. we currently oversee them about $40 trillion. we have more in this coming year. this is to deal with data. we will need to be able to put a pipeline into that. there are alert on 300 different w
are fully authorized. there are special categories by resolution 1929 that are prohibited. and turkey has clearly indicated publicly that it will abide by it s international obligations. thank you. : president obama talked earlier about the s.t.a.r.t. treaty with russia and tax cuts. he spoke reporters following the meeting with the president of poland. before i mention the substance of our meeting let me say something very quickly that it s on everybody s mind and that is the current debate about the tax we have come up with. [inaudible] we announced this agreement and over the last couple of days but congress has looked of what would be the result of getting this agreement and i think it s worth noting the majority said upwardly revised forecast for economic growth, and noted that in the conflict of disagreement we expect more of growth in 2011 and 2012 than they originally anticipated. it s important for congress to examine the agreement, look at the facts, have a thor